Abstract
The reproducibility of ambulatory 24-h esophageal pH monitoring was evaluated in 16 consecutive patients by comparing the difference in two consecutive 24-h periods. The study group included 8 patients with scleroderma esophagus and 8 treated achalasia patients. The amount of reflux was expressed as the percentage of time the pH was <4.0. Both groups demonstrated excellent intrapatient reproducibility overall: 96% in scleroderma patients and 95% in those patients with achalasia. The least concordance was found in the lengths of the longest reflux event—70% when supine in scleroderma patients and 59% when upright in patients with achalasia. There was no significant difference (p>0.05) between day 1 and day 2 for either group of patients for any of the elements studied. These results indicate that intrapatient variability of gastroesophageal reflux in patients with scleroderma esophagus and treated patients with achalasia is very low and following therapeutic intervention, a high level of confidence can be placed in subsequent pH monitoring as an indicator of treatment effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Johnsson F, Joelsson B: Reproducibility of ambulatory oesophageal pH monitoring. Gut 29:886–889, 1988
Wiener GJ, Morgan TM, Copper JB, Wu WC, Castell DO, Sinclair JW, Richter JE: Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 33:1127–1133, 1988
Vandenplas Y, Helven R, Goyvaerts H, Sacre L: Reproducibility of continuous 24-hour oesophageal pH monitoring in infants and children. Gut 31:374–377, 1990
Hampton FJ, MacFadyen UM, Simpson H: Reproducibility of 24-hour esophageal pH studies in infants. Arch Dis Child 65:1249–1254, 1990
Hendel L, Hage E, Hendel J, Stentoït P: Omeprazole in the longterm treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther 6:565–577, 1992
Shoenut, JP, Wieler JA, Micflikier AB: The extent and pattern of gastro-oesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole. Aliment Pharmacol Ther 7:509–513, 1993
Sauer L, Pelligrini CA, Way LW: The treatment of achalasia. A current perspective. Arch Surg 124:929–932, 1989
Thomson D, Shoenut JP, Trenholm BG, Teskey JM: Reflux patterns following limited myotomy without fundoplication for achalasia. Ann Thorac Surg 43:550–553, 1987
Kerr P, Shoenut JP, Millar T, Buckle P, Kryger MH: Nasal CPAP reduces gastro-esophageal reflux in obstructive sleep apnea syndrome. Chest 101:1539–1544, 1992
Kerr P, Shoenut JP, Steens RD, Millar T, Micflikier AB, Kryger MH: Nasal continuous positive airway pressure: a new treatment for nocturnal gastro-esophageal reflux? J Clin Gastroenterol 17:276–280, 1993
DeMeester TR, Wang C-I, Wernly JA, Pellegrini CA, Little AG, Klementschitsch P, Bermudez G, Johnson LF, Skinner DB: Technique, indications, and clinical use of 24-hour esophageal pH monitoring. J Thorac Cardiovasc Surg 79:656–670, 1980
Richter JE, Bradley LA, DeMeeser TR, Wu WC: Normal 24-hour ambulatory esophageal pH values. Influence of study center, pH electrode, age and gender. Dig Dis Sci 37:849–856, 1992
Halpert RD, Laufer I, Thompson JJ, Feczko PJ: Adenocarcinoma of the esophagus in patients with scleroderma. AJR 140:927–930, 1983
Cameron AJ, Payne WS: Barrett's esophagus occurring as a complication of scleroderma. Mayo Clin Proc 53:612–615, 1978
Hendel L, Stentoft P, Hage E: Omeprazole in the treatment of reflux esophagitis in patients with progressive systemic sclerosis (Abstract). Gastroenterology 96:204, 1989
Shoenut JP, Kerr P, Micflikier AB, Kryger MH: The effect of nasal CPAP on nocturnal reflux in patients with scleroderma esophagus (Abstract). Gastroenterology 104:192, 1993
Lee FI, Bellary SV: Barrett's esophagus and achalasia. J Clin Gastroenterol 13:559–561, 1991
Feczko PJ, Ma CK, Halpert RD, Batra SK: Barrett's metaplasia and dysplasia in post-myotomy achalasia patients. Am J Gastroenterol 78:265–268, 1983
Murphy JR, McNally P, Peller P, Shay SS: Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis. Dig Dis Sci 37:833–841, 1992
Smart HL, Foster PN, Evans DF, Slevin B, Atkinson M: Twenty-four-hour oesophageal acidity in achalasia before and after pneumatic dilatation. Gut 28:883–887, 1987
Shoenut JP, Micflikier AB, Yaffe CS, Den Boer B, Teskey JM: Reflux in untreated achalasia patients. J Clin Gastroenterol 20:6–11, 1995
Stentoft P, Hendel L, Aggestrup S: Esophageal manometry and pH-probe monitoring in the evaluation of gastroesophageal reflux in patients with progressive systemic sclerosis. Scand J Gastroenterol 22:499–504, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shoenut, J.P., Micflikier, A.B., Aldor, T.A.M. et al. Reproducibility of ambulatory esophageal pH monitoring in the aperistaltic esophagus. Dysphagia 11, 248–251 (1996). https://doi.org/10.1007/BF00265209
Issue Date:
DOI: https://doi.org/10.1007/BF00265209